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In 2017, an estimated 27,980 women will be diagnosed with breast cancer in California, and 
approximately 4,440 will die from the disease.1 Unfortunately, it appears uninsured and 
underinsured breast cancer patients continue to face delayed and restricted access to life-saving, 
life-extending treatments and to services that enhance quality of life.  A landmark study 
published in 2015 using the California Cancer Registry found patients with stage III breast cancer 
had the best 5-year relative survival if they were covered by private insurance (80.3%) while 
Medicare-Medi-Cal dual eligible and uninsured patients had the lowest 5-year relative survival 
rates (59.4% and 62.5%, respectively). Approximately 60% of women with stage 0-II breast 
cancer with private insurance (and 61% with Medicare) underwent breast-conserving surgery, 
compared to 52% with Medi-Cal and 53% who were uninsured.  Health coverage improves 
breast cancer outcomes compared to those with no insurance, but challenges may remain even 
for the insured. Among those insured, there appear to be significant health system barriers to 
cancer care as health insurance premiums and the cost of breast cancer drugs are increasing, 
and provider networks are narrowing.  
 
This report provides an assessment of the significant barriers and challenges to accessing breast 
cancer care in California by insurance status (uninsured, underinsured, on public or private 
health insurance). This was accomplished through a synthesis of the peer reviewed literature, 
news media, reports and policy briefs, social media, legislative scan, and a series of key 
informant/stakeholder interviews. This assessment synthesized the findings from these differing 
yet interlinked sources of information, producing the themes as well as specific barriers 
identified as the most significant for women with breast cancer in California. We report here in 
this Executive Summary the Key Findings of the report.  These findings can be used to guide 
efforts of policy-makers to improve timely access to breast cancer care among all women in 
California.   
 
This updated report represents a compilation of 2 phases of the study. In Phase 1 (Patient 
Perspectives), research included a review of literature and social media, legislative scan and key 
stakeholder interviews with patient educators and navigators.  Phase 1 key informants were 
recruited from patient education, support, and advocacy groups. In Phase 2 (Provider 
Perspectives), a second round of stakeholder interviews was conducted with health care 
providers and social workers.  
 
It is important to note that the timeline of this study corresponded with a dramatically changing 
political environment with potential implications for breast cancer care. The early phase of the 
study occurred in early 2016, prior to the 2016 Presidential Election.  However, the second phase 
occurred after the election and the United States Congress and the newly-elected Trump 
administration have been working on a repeal and/or replace of the Affordable Care Act (ACA). 
In May 2017, the United States House of Representatives voted to pass the American Health 
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Care Act (AHCA), as a replacement to the Affordable Care Act. While the AHCA has not yet been 
voted on by the United States Senate as of July 2017. 
 
It is clear that the AHCA is changing the landscape of the discussions on health care, with the 
return in conversations on who gets access, what is the scope of coverage and how much more 
will people pay, especially for people with breast cancer and other chronic conditions that incur 
expensive treatments. According to the Congressional Budget Office score as of May 24, 2017, 
the House version of the AHCS would result in 23 million people losing coverage—largely 
through the repeal of the ACA’s provision to expand Medicaid eligibility. Affordability would also 
be affected by reduced subsidies for non-group insurance and elimination of lifetime coverage 
limits. The House AHCA replaces the ACA’s protections from denial of coverage of people with 
pre-existing conditions with access to coverage through high-risk pool coverage programs. The 
AHCA’s current provisions have been debated to be inadequate to meet the needs of people 
with pre-existing conditions where their only option is to purchase health insurance through the 
non-group market.   Our report thus uniquely presents insights on barriers to breast cancer care 
straddling a period of the Obama and Trump presidential administrations.   
  
 
Key Findings of the Report 
 
After collecting data on the key barriers to breast cancer treatment faced by women in 
California, the barriers were organized into 5 common themes.  Below, we provide a table 
featuring policy insights that hone in on the issues of key concern identified in this report for the 
five identified themes by insurance type.  We anticipate that these project results can be used to 
guide efforts of policy-makers to improve timely access to breast cancer care among all women 
in California.   
 
 
Policy Insights by Theme and Insurance Type 
Themes Uninsured & 
underinsured 





State policy that 
bolsters the 
preservation of 
coverage for the 
uninsured given 









under the ACA & 
policy focus on 
specifically 
improving the 
quality of care 
provided to Medi-
Cal enrollees to 
address disparities 
that currently exist  
 
State policy targeted 
to the ensuring 
subsidy support for 
Covered California 
and ensure low 
income population 
has access to 
navigation and 




these services, and 
promotion of 
system integration 
State policy to mandate navigation services, reimbursement for these services, and 
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Themes Uninsured & 
underinsured 
Medi-Cal Covered California Private/commercial 
insurance 
consideration of payment models that encourage care coordination  
Insurance/Health 
Benefits 
Policy mandates to 
extend program 
















Policies that limit 
narrow provider 
networks, with focus 
on improving 




of a plan’s covered 
benefits for 
reconstructive 
surgery and second 
opinions. 
 
Policies that streamline authorization processes and meet a set target for 
turnaround time. Women face delays in care due to prolonged insurance 
authorization, thus failing to receive timely treatment  
 
Cost State policy that 
bolsters the 
preservation of 
coverage for the 
uninsured given 
the uncertainty of 
the ACA; 
 














childcare, and lost 
wages 
State policy targeted 
to the ensuring 
subsidy support for 
Covered California; 
 
Policies that restrict 
placement of 
essential oncology 
drugs on the highest 
cost tier and other 
policies that address 
high costs of 
oncology drugs 
Policies to reduce 
the burden of costs 
to enrollees from 
treatment and 






tools to consumers 
regarding costs of 
care, for example 
cost calculators, lists 
of all covered breast 
cancer drugs, up-to-
date formularies & 
information on tiers 
and restrictions on 
drug access, 
provider directories 
and information on 
in and out of 
network use of 
providers and costs 
 Consider health system reform cost containment strategies that increase affordability 
of breast cancer care.  
 













services to improve a 
patient’s geographic 




models that reward 
providers and larger 
health delivery 
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Themes Uninsured & 
underinsured 
Medi-Cal Covered California Private/commercial 
insurance 
undocumented 








provider’s ability to 





to patients who 
need them 
 
State programs such as the Office of Health Equity should provide resources and 
programs to encourage cultural competency training for health providers on 






proficient women  
to increase their 
awareness of 




(BCCTP)  for breast 
cancer care  
Incentivize 
providers more to 
provide language 





with payment for 
in-language 
navigation services 




that extend beyond 
the visit, to include 
the entire span of the 




and support services 
Support programs 
that expand the 
number of 
providers who are 
bilingual, and 
incentivize the use 
of language services 
Enforce compliance of the law of the Health Care Language Assistance Act and the 
ACA section 1552 across all health plans especially Medi-Cal plans that serve a 














In 2017, an estimated 27,980 women will be diagnosed with breast cancer in California, and 
approximately 4,440 will die from the disease.1 Research has documented disparities in breast 
cancer outcomes by socioeconomic status and race/ethnicity.4 Although the factors underlying 
disparities are complex and multi-focal, unequal access to high-quality breast cancer treatment is 
likely a key cause of disparities in breast cancer outcomes.5,6 Prior research examining barriers to 
care have identified barriers that are structural (e.g., access to services, geographic location of 
services, transportation needs, insufficient or undertrained workforce), sociocultural (e.g., 
misconceptions, stigma, language barriers, discrimination, religious beliefs), personal (e.g., fear 
of a cancer diagnosis, low health literacy, competing family and work obligations) and financial 
(e.g., lack of insurance, large out-of-pocket payment, indirect costs of transportation, childcare, 
and lost wages).4,7-11  
 
Since its major implementation in 2014, provisions of the Affordable Care Act (ACA) has 
successfully expanded access to health insurance and breast cancer care.  Today, in 2017, 
Federal legislative discussions on repeal of the ACA brings new concerns on unraveling the gains 
from the ACA as millions of women facing a new diagnosis of breast cancer will lose coverage 
and will lose protections in purchasing coverage. Uninsured and underinsured breast cancer 
patients continue to face delayed and restricted access to life-saving, life-extending treatments 
and to services that enhance quality of life.  
 
Although insurance improves breast cancer outcomes compared to those with no insurance, 
challenges remain even for the insured. Among those insured by their employers, there may be 
significant barriers to cancer care as health insurance premiums are increasing; for example, in 
California, health plan premiums have increased by 189% between 2002 and 2014, and 28% of 
large California firms reduced health benefits or increased cost sharing in 2014.12 Among both 
the publicly and privately insured, other barriers to cancer care include delays in timely access to 
specialists in oncology, narrow networks of breast cancer specialists, restricted prescription drug 
formularies for oncology drugs and oncology support (e.g. drugs for chemotherapy-related 
anemia), all of which affect patients facing costly cancer treatment. Access may still be a barrier 
as a growing number of insured patients are discovering that their oncology care providers were 
no longer considered in-network. In March 2014, the Centers for Medicare & Medicaid Services 
(CMS) responded with network adequacy standards to help determine whether health plans 
offered in healthcare exchanges provide access without unreasonable delay to certain health 
care providers, including oncology providers and hospital systems.  
  
This report provides a comprehensive assessment of the significant barriers and challenges to 
accessing breast cancer care in California through the three key approaches: (1) a synthesis of 
the peer reviewed literature, (2) an analysis of social media and the grey literature (news media, 
reports, and policy briefs), (3) completion of a series of key informant/stakeholder interviews. A 
legislative scan was also conducted to understand the types of policies that have been 
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introduced to address barriers and then to identify the gaps in policy that could be filled by new 
legislative action (see Appendix E).  Although many barriers are shared across insurance types, 
where possible, we provide insight on barriers unique to the insurance status of women, 
specifically for the uninsured, those covered by Medi-Cal, and those covered by commercial 
insurance. We anticipate that these project results can be used to guide efforts of policy-makers 
to improve timely access to breast cancer care among all women in California.   
 
Technical Approach 
Approach 1: A Narrative Synthesis of the Barriers to Breast Cancer Care   
We conducted a narrative synthesis review of the recent evidence (January 2013-December 
2015) on the barriers to breast cancer care in the U.S. and California.  As part of our review, we 
included both the peer-reviewed literature as well as non-peer reviewed sources. A literature 
search was performed to retrieve publications that described any aspect of barriers to breast 
cancer care for which a conceptual framework helped identify search terms (see Appendix A for 
conceptual framework and list of terms). The literature search was limited to articles published 
in English from 2013-2015. A total of 710 papers were retrieved in this search; 99 of these were 
studies/papers based on California data.  We then reviewed and sorted the list to exclude papers 
on prevention, early-detection, and screening.  With examination of the titles and abstracts, the 
list of papers was then further narrowed down to only papers that made reference to barriers to 
care.  
 
Approach 2.  Examination of Gray Literature and Social Media  
 
For the gray literature (news media, reports, and policy briefs) synthesis, a total of 35 papers (of 
which 15 are California-based) were identified and full text articles were retrieved. Over 100 
articles were retrieved in the non-peer reviewed search with mention of health care barriers 
post-ACA. However, the vast majority of these articles were duplicate reports of findings that 
had been published in peer-reviewed journals. The most relevant non-peer reviewed sources on 
potential health care barriers in California are reports from the California Health Care 
Foundation, which have been used throughout this report to provide context and insight 
regarding the current landscape of healthcare in California and its potential influence on breast 
cancer care.  
 
Social media – for example, Twitter and Facebook – are a major repository of information to 
examine campaigns by organizations and to capture the conversations/discussions among 
members of the public that occur in these platforms. In 2014, about 23% of adults online used 
Twitter (up from 18% in 2013) and approximately 71% of adults online use Facebook, and the 
usage among older adults is increasing.13 
 
In social media analysis, identifying particular hashtags or keywords are crucial as they are the 
means to identify data that speak to a particular problem. For this purpose, we harvested 
 3 
hashtags and names of breast cancer patient organizations with a presence on social media from 
our key informant interviews and the gray literature review.   
 
Findings from the social media scan were combined with the gray literature because there was a 
good deal of alignment between the gray literature and social media, namely because much of 
the discussion occurring on platforms such as Twitter and Facebook are related to gray literature 
news articles.  
 
Approach 3:  Key Informant Interviews to Understand Patient Barriers to Care   
An important aspect of this project is to gain an understanding of barriers to breast cancer care 
in California from the perspective of both the patient and the provider. In an effort to represent 
a maximum amount of voices, the research team identified organizations that interface directly 
with breast cancer patients and would be in a position to hear feedback from patients on their 
perceptions of the continuum of care. Thus, to gain insight from the patient’s perspective, key 
informants included breast health educators, on-site clinic workers, patient navigators, and 
individuals involved with support groups. In order to recruit participants for key informant 
interviews, we invited organizations that have previously partnered with the UCLA Center for 
Health Policy Research, the UCLA Center for Cancer Prevention and Control Research, and the 
California Pan Ethnic Health Network, resulting in the completion of 12 key informant interviews 
from the patient perspective. In Phase 1, semi-structured interviews were conducted by phone 
from January 3 – March 18, 2016. In Phase 2,  a second round of interviews were conducted with 
health care providers. To ensure representation of providers working across the entire breast 
cancer care continuum, recruitment efforts targeted a broad spectrum of providers including 
primary care providers, breast surgeons, medical and radiation oncologists, medical directors, 
program administrators, and social workers. These providers worked in a variety of health care 
settings including public and private hospitals, private practices, safety net clinics, and support 
programs. Eleven interviews were conducted by phone April 12 – May 17, 2017.  
The semi-structured interviews were designed to assess barriers to breast cancer care across the 
continuum of care. Respondents were also asked to describe how the experience of a patient 
obtaining care may differ based on insurance status – uninsured, underinsured, and publicly or 
privately insured. (see Appendix B for list of codes). 
Our goal was to recruit informants who collectively can provide input on the range of health 
insurance experiences of California cancer patients and the barriers that these patients face. 
Using snow-ball sampling technique, we identified known key informants, including members of 
the California Breast Cancer Research Program staff and its Policy Research Advisory Group, who 
could provide recommendations for, and connections to, study participants meeting our criteria 
of representative providers, organization types, and geographic locations. Across Phases 1 and 2, 
we sought to achieve diversity in geography across in California. Our final sample included 
informants from Berkeley, Chico, Duarte, El Dorado Hills, Fresno, Greenbrae, Long Beach, Los 
Angeles, Oakland, Redlands, Sacramento, San Francisco, Santa Monica, and Visalia, many 
working in health systems serving patients from wider geographical areas. The sample includes 
 4 
informants with programs that cater to specific race/ethnic groups in order for project findings 




As intended, each Approach generated themes on differing yet interlinked sources of barriers to 
breast cancer care and disparities in treatment. Using the findings from the approaches 
described above, the appearance of keywords related to the barrier addressed were 
documented and then tallied. The predominant keywords that emerged in the narrative 
synthesis, key informant interviews, and the scan of social media/gray literature were then 
compared to identify major themes.  The following barrier themes were identified as the most 
significant for women with breast cancer in California: (1) Health System Fragmentation and 
Navigation, (2) Insurance/Health Benefits, (3) Cost, (4) Individual and Cultural Characteristics, and 
(5) Language.  Table 1 presents a “heat map” of the frequency of mentions of each theme 
generated by the key informant interviews, peer-reviewed literature, and gray literature/social 
media.  (see Appendix F for detailed summary table and figure). 
 





















Fragmentation/Navigation          
Insurance/Health Benefits         
Costs         
Individual/Cultural         




Most often mentioned Medium 
Least or No 
mention 
      
 
The peer-reviewed literature focused on variations in receiving timely and high-quality care by 
individual patient characteristics (e.g. race/ethnicity); there was also a body of literature that 
elaborated on the role of patient navigation in addressing patient level barriers to care. The gray 
literature/social media space, however, delved in conversations on high cost of treatment and 
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narrow provider networks in insurance markets. Key informant Phase 1 interviews highlighted 
patient-level barriers and the ways in which system-level barriers compounded patient-level 
challenges. Phase 2 interviews, similar to the gray literature /social media scan identified 
insurance and cost issues as top barriers.  To a lesser degree, Phase 2 interviews also reinforced 
the health system and navigation barriers raised in both the peer-reviewed literature and in the 
key informant interviews from the patient perspective.  Across all Approaches, language barriers 
registered as a top theme, with the exception of the social media approach, where it was least 
mentioned.  Social media posts may tilt towards the experience of care among English-proficient 
women with breast cancer.   
 
We also probed from our quantitative and qualitative data sources whether these themes vary 
by insurance status.  While there are specific barriers, such as public program time limits for 
treatment for uninsured women, we found that a multitude of barriers cross insurance lines. No 
single insurance status – uninsured, underinsured, and publicly or privately insured – exempts 
women with breast cancer from the possibility of facing barriers identified by this study.  Not 
surprisingly, we did find that among women with breast cancer who are insured, barriers are 
often patient-centered.  Among women without insurance, system-level barriers dominate, 
delaying and restricting access to life-saving, life-extending treatments. 
 
Our approach provides insights from multiple perspectives and key informant interviews at two 
pivotal points of time for our federal healthcare system. Our interviews from the patient 
perspective began in early 2016, a recent period post the major implementation in 2014 of the 
Affordable Care Act (ACA), where expanded coverage evolved the health access discourse to 
concerns on narrow networks and improving the patient experience. Our second set of 
interviews in 2017 aimed to pair the patient perspectives with provider perspectives on barriers, 
but these insights were of course shaped by federal legislative activities to repeal the ACA, thus 
propelling the return of coverage concerns as a top barrier. Taken together, our project provides 
current evidence to inform removal of critical barriers to breast cancer care for Californians—
where some barriers are constant regardless of coverage whereas other barriers would be 
amplified with potential repeal of the ACA. Below, we organize our findings and our 









Health System Fragmentation / Navigation 
 
Data collected across all Approaches emphasized the fragmentation of the health system as a 
major barrier to the receipt of timely, high quality care. The lack of connections between 
providers, facilities, and payment systems add to the challenges of receiving cancer care that is 
already complex, involving treatment and support from multiple providers and services. For 
example, one respondent noted a challenge at her facility dealt with prescribing radiation, 
because the facility had to refer patients elsewhere for treatment, which caused delays in care. 
Services that are integrated and co-located can lead to improved timeliness and completion of 
care.  
 
Another respondent expressed frustration in the lack of coordination: “In Los Angeles County, 
perhaps even in the state, we just had a spider web of different programs, and that spider web 
left plenty of room for people to fall through the cracks.”  The lack of coordination has also been 
cited as a barrier to effective breast cancer care by providers in California and is considered one 
of the key challenges in cancer care.14,15 
 
Patient navigation could counter the challenges of system fragmentation. Navigation helps 
patients overcome barriers to cancer care through care coordination and support. Patient 
navigation emerged as a significant theme in this study, both as something that was desperately 
needed when absent, and extremely helpful when present (which was less often the case). 
  
A seminal article on patient navigation by Wells and colleagues (2008) provides an ideal frame 
for considering our results; in their paper the following five characteristics are used to describe 
patient navigation for cancer - 1) it focuses on overcoming individual patient level barriers to 
accessing care; 2) it reduces delays in obtaining care; 3) is provided to patients for a defined 
episode of cancer care; 4) focuses on a defined set of health services relevant to that episode of 
care; and 5) has a definitive endpoint when provided services are complete.16 Patient navigation 
is most commonly offered by health services providers (hospitals or physician practices), and less 
often by health insurance plans.   A large body of scientific research has documented the 
benefits of navigation for patient satisfaction and clinical outcomes.10,17-24   
 
Many interview respondents had direct experiences demonstrating the need for navigators. 
More than one acknowledged that their organization was not explicitly tasked with navigation 
services, but often ended up playing the role. Screening and community outreach programs in 
particular – because they are a known entity – become de facto resource centers and, in some 
cases, provide navigation because women don’t know where else to go. But their services are 
limited by their often indirect link to any one health care system.  
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One provider noted this was particularly important for women who are new to certain programs 
such as the revised Medi-Cal program. 
 
“I would think that, at least in our state, the change from Medi-Cal to the HMO 
plans where women are covered by certain groups, I don’t think that gets 
explained to them very well and I don’t think they understand how that works 
until they try to make an appointment with the doctor.”    
 
Another important role for navigators is to connect women with non-medical support services. 
Even though many services for breast cancer patients currently exist, these services are likewise 
fragmented and can be challenging to locate and connect with. One patient educator mentioned 
that she often hears from cancer patients and survivors the desire to start their own support 
service organizations, because they had not been able to find the services they needed for 
themselves.  
 
“I said (to the patient) you mean to tell me you have founded an organization that 
provides hats and wigs for women? And she was like, yeah. And I said ‘why don’t 
you join (with) this other organization…..this is what (they do). ” 
 
Findings from the key informant interviews indicated differences in availability of existing 
navigation programs by health insurance, and which providers/programs best supported patient 
navigation.  
 
Other respondents noted that some specific insurance plans, but not all, play a role in access to 
navigation. One reported that HMOs help with navigation better than other plans.  However, one 
respondent provided this insight:  women with private insurance are assumed to have a support 
system, and thus those receiving care from private providers were generally less likely to be 
offered patient navigation services.   On the other hand, some respondents suggested that 
healthcare safety net providers, such as public health systems and Federally Qualified Health 
Centers, were most helpful with navigation. 
 
Some respondents particularly noted the value of navigators in the context of a change in 
insurance status, particularly for the newly insured population under the ACA who have very 
limited experience inside a medical system.  
 
One provider-based navigator offered this opinion:   
 
“I think the navigation function is incredibly important, especially for our highest 
risk patients. There’s plenty of online nutrition information, and exercise videos out 
there and whatever, there’s access to all kinds of expertise, but the function of 
someone whose job it is…to look over the shoulder of the patient and make sure 
that they are getting to their appointment on time, making sure that they are 
signed up for the services they need, making sure that they are getting a ride to 
their radiation, it’s invaluable, especially for our highest risk patients.” 
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Overall, although informants differed in their opinion of specific health care settings, most 
agreed that a well-run navigation program was valuable for helping women succeed in moving 
through the complex process of receiving high quality breast cancer care. However, there is a 
key difference in the perspectives of patient educators and of providers. Often, the providers 
that noted the value of navigation were associated with facilities that had social workers and/or 
navigation services available to their patients. This perception reveals a gap in the patient 
experience, as the patient educators that participated in this study, most of whom are outside 
physician practices, reported that patients they talked with were not getting sufficient services, 
particularly navigation.  
 
Respondents indicated that navigation programs varied in the range of services offered as well as 
quality. There was consensus that navigation cannot stop at the hospital doors, and must extend 
to support services. Respondents felt strongly that navigators should:  
 
 Communicate with the doctors to help ensure timely delivery of services. 
 Follow-up on mail sent to patients, ensure timely follow through. Lack of follow-through 
could force changes in insurance, impacting care.  
 Help interpret technical medical terms into common language to explain the diagnosis 
and treatment options, enabling the patient to make more informed decisions about 
care.  
 Be available to all women, regardless of insurance status; some women who have 
insurance still do not know how to navigate the health system. 
 Have a repository of resources for support services for referrals. Often providers and 
their staff are unaware of outside programs.  
 
 
Respondents also noted challenges in implementation of quality navigation services. First, HIPPA 
regulations can cause issues with programs that are not officially tied to a hospital or provider, as 
doctors cannot discuss private patient information with a third party. These barriers are 
amplified when the navigator is assisting someone with limited English proficiency, and is 
needed to help translate clinical discussions with providers, schedule appointments. Second, 
there may be a lack of coordination between providers and navigators, particularly if providers 
are unfamiliar with community-based navigation programs. Third, navigators who are not 
knowledgeable about support services may not be as helpful as those with experience both in 
healthcare and community resources. 
 
Several provider respondents noted the presence of navigators within their practices, and felt 
their services were extremely valuable to patients.  
 
“Our navigator is absolutely wonderful, there’s only one of her, so she does get 
stretched kind of thin, but especially for our most vulnerable patients, I think that 
single service has made the most difference.” 
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These provider respondents were associated with a facility such as a comprehensive care clinic 
with co-located services. But one provider noted that is not always the case: 
 
“Some providers are well-equipped with a list of different resources and some 
providers have case managers. They have a front staff that maybe not assigned 
any specific name but they have specific duties to provide patient support and 
provide case management so they can tell women how to get (help), maybe give 
her free tickets for bus rides or for some sort of, some other commuters. Other 
clinics, they have extensive lists of peer support and charity organization, but not 
all the offices are well-equipped like that. Actually most of the time they’re not, 
especially if these are the small offices. In small offices and solo practices, it’s 
usually one staffer who’s front desk or manager does everything and it’s a lot of 
things fall between cracks.”   
 
A few patient educator and provider respondents noted either recent expansion of navigator 
activities, or planned expansion to meet patient needs. One provider spoke specifically about 
efforts at her facility: 
 
“Our facility has case management so we try our best to offer when we find 
patients in need in like a dire situation or may need food stamps we would send 
them to get those services.” 
 
The role of a navigator does not need to be limited to serving the patient. Due to their intimate 
knowledge of challenges, barriers, and possibly successful solutions, they can feed back valuable 
information to providers and health systems. One respondent relayed a specific example of a 
Thai health navigator, who was well known to local health systems. Area hospitals provided her 
parking access and a badge, and designated certain days for screenings of Thai women. The 
navigator participates on the health system’s tumor board, where she helps the provider 
understand the patient perspective in treatment decisions. She offers the point of view of a 
patient and women, commenting on what was being recommended and what could be a barrier 
to care. This is an example of a successfully collaborative relationship between providers and 
navigators.17,19,25-29 A recent study shows patient navigation resulted in a more timely diagnosis 
for a diverse group of minority, low-income women with breast cancer screening 
abnormalities.30 
 
One respondent noted that her organization recognizes that patients have better outcomes 
when they work with a patient navigator to develop an individual treatment plan: 
 
“Not everybody has the ability to understand their choices or make medical 
decisions without having something really laid out in front of them that 
specifically. Especially for medically underserved patients who do experience 
limited access to medical care and they have language barriers.” 
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In our literature retrieval, a study on patient navigation argued for the need for navigators to be 
better trained to identify legal issues their patients are facing as a part of their patients’ cancer 
treatment plan.31 Patients are protected by non-discrimination laws directed at housing and 
employment. Patients who are unaware and face issues with their jobs or residences will face 
additional barriers beyond treatment.  
 
Fragmentation of the payment system as a barrier to timely access to quality cancer care was 
also raised in both the peer reviewed literature and key informant interviews.  In the peer-
reviewed literature, there is a large body of recent research on new payment models for cancer 
care coordination, with the bulk of the literature focusing on financial incentives for adhering to 
clinical pathways, patient-centered medical homes, bundled payments, and specialty 
accountable care organizations (ACOs).46-50 There have also been calls for more radical change, 
with the endorsement of single payer system - in the cancer literature. The single-payer program 
is likened to Medicare for all in which it would provide universal, comprehensive insurance– 
covering provider visits, hospital care, prescription medication, and long term care and 
rehabilitation.51 The calls for single payer, however, have been called aspirational and there 
remains uncertainty regarding how a shift of this nature would be implemented in the U.S.52 
California is at the forefront of this issue as it is debating legislation that would create a 
statewide single-payer health care system. The Healthy California Act (SB-562), 2017 would 
provide health care to all Californians, including those who are currently either uninsured or 
underinsured.  
 
Four of the 11 providers interviewed felt that there is a need to revisit healthcare delivery 
systems and financing mechanisms altogether for a way forward in facilitating care coordination 
and reducing costs of care for breast cancer treatment. As our interviews coincided with the 
policy discussions on SB-562, there adopting a single-payer health care system was called out as 
a viable policy solution to reforming health system fragmentation. 
 
“If we’re talking about reform policy changes moving towards, you know, single-
payer health is huge.” 
 
One provider stated: 
 
“Even though it would be very messy to get here, I think the cleanest thing would be like 
a single-payer healthcare system because there’s so much waste in the system that we 
have now with all these levels of different insurances and everybody, there’s so many 
resources spent on, you know, middlemen basically. So if it was up to me I would choose 
single-payer.” 
 
Another provider offered:  
 
“From a policy standpoint I have always felt that a universal single payer health 
care system is far and away the most functional thing…” 
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A report by the Political Economy Research Institute at the University of Massachusetts Amherst 
examined SB-562’s provisions and estimated that the single payer system could produce savings 
of about 18%.53 While the immediate costs and savings of a single payer system may still be up 
for debate, it is the long term administrative efficiencies associated with eliminating the 
fragmentation of multiple payers that appears to be the strength of the economic argument for 
this system.52    
 
Recommendations to Address Health System Fragmentation/ Navigation Barriers 
 Improve system integration and co-location of services, including connections to, and 
financial support for, social services.  
 Provide reimbursement for patient navigation services, especially in private health plans 
that currently lack these services.  
 Establish quality standards for patient navigation.   
 Expand existing screening and prevention programs to educate women diagnosed with 
breast cancer on patient navigation, including what the role of a navigator is, what 
services are included, and how to obtain navigation services. 
 Support the development of a repository of information on health care service providers 
and support services that can be locally tailored and available to providers and 
navigators. 





Type of insurance and the structure of health benefits been shown as a strong determinant of 
variation in breast cancer treatment decisions and outcomes.  A study published in 2015 using 
the California Cancer Registry examined outcomes by type of health insurance among about 
700,000 Californians diagnosed with breast, colon, rectal, lung, and prostate cancer between 
2004 and 2012.32 They tracked how early cancer patients were diagnosed, their quality of 
treatment and their five-year relative survival rates according to their type of insurance. Among 
a number of findings, the study reported that Medi-Cal patients with stage 0-II breast cancer 
were the least likely (52.2%) to receive breast-conserving surgery. Breast-conserving surgery 
followed by radiation therapy is generally regarded as the optimal treatment for most, as it 
largely mitigates the psychosocial and clinical consequences associated with the more invasive 
mastectomy.33 Medicare patients were significantly more likely to receive breast-conserving 
surgery (61.1%) than patients having any other source of insurance. Breast cancer patients under 
70 years of age, who were uninsured, or had Medi-Cal coverage, were the least likely to receive 




Providers in this study provided additional examples of insurance status (specifically participation 
in Medi-Cal) impacting care, particularly during the diagnostic phase. However, some of their 
perceptions were contradictory. One provider reported that Medi-Cal did not cover a PET Scan. 
 
“For example, right now if a woman is suspected to be metastatic, have 
metastatic breast cancer at diagnosis, private insurance will cover a PET-CT, which 
is a way of looking for metastasis in the liver or in the bones, but Medi-Cal does 
not cover that. Those women have to get CT scans and they have to get a nuclear 
medicine bone scan. Medi-Cal does not cover a PET_CT.” 
 
Another provider shared that the scan was covered, however, approvals significantly delayed 
care. 
 
“I have less trouble getting people worked up in, under the Partnership heading, 
which is our Medi-Cal, it just takes forever.” 
 
In breast cancer care, there may not always be a definitive guideline or evidence base to 
determine whether one treatment is “better” than another. Ideally, providers and patients 
would then engage in a shared decision-making process to select among treatment alternatives; 
insurance status would not have an impact on treatment decisions. However, we identified two 
studies that found that insurance status was also related to receipt of two types of treatment. 
 
 Bilateral mastectomy. Although removal of only the breast cancer tumor or the affected 
breast is the most typical surgical treatment for breast cancer, bilateral mastectomy use 
is increasing over time. The increase in use of bilateral mastectomy may be indicated, 
especially when results of genetic testing results suggest the potential benefit, or may 
reflect overtreatment among more affluent populations. In a study of California women 
who had undergone surgery, women who had unilateral mastectomy have public/Medi-
Cal insurance, and were treated in hospitals serving predominantly patients of lower 
SES.34,35 Another study found that women who underwent bilateral mastectomy were 
more likely to be non-Hispanic white and privately insured, to live in high SES 
neighborhoods, and to be treated in NCI-designated cancer centers.19 
 Brachytherapy. Radiation therapy is accepted as an important component of adjuvant 
treatment of breast cancer. For patients with certain disease characteristics, 
brachytherapy (radiation therapy given in or near the tumor itself such that a high 
radiation dose hits the tumor while reducing the radiation exposure in the surrounding 
healthy tissues) is considered to be a relatively cost-effective alternative to traditional 
external beam radiation therapy.  In a national study, among patients who had Medicaid 
coverage or were uninsured brachytherapy was less often used in the definitive or 
postoperative management of cancer compared to those with non-Medicaid insurance.36   
 
Findings from key informant interviews suggest that treatment paths may vary by insurance 
status in part due to the providers and facilities that a patient can access. There is no doubt that 
there has been a growth in health insurance plans offering limited provider networks: A 
 13 
California Health Care Foundation report in 2015 reported that Covered California plans offered 
narrower hospital networks than commercial plans.37 However, they also found the quality of 
care (measured using an index made up of twelve AHRQ quality indicators reported by California 
hospitals) provided by these restricted networks was not significantly different than the care 
provided in non-Covered California plans, and in some cases may be of higher quality.38 There 
have not been studies examining quality, including timeliness, of care, of Covered California 
plans specifically for breast cancer.  
 
There were limited findings in regard to narrow networks specifically under Covered California. 
In key informant interviews, one patient educator respondent noted the presence of cultural 
issues, rather than reimbursement issues, affecting access for patients with insurance under 
Covered California: 
 
“The (geographic) area is also conservative, and some providers will not accept 
certain insurance because they don’t want to appear to support Obamacare.”   
 
However, several patient advocates reported that women have had difficulty finding providers 
that accepted Medi-Cal or uninsured patients. One respondent noted Medi-Cal reimbursement 
rates as an issue contributing to narrow networks:  
 
“The decrease in Medi-Cal reimbursement rates for providers is posing a huge barrier 
for us. We see our network of referral providers diminishing on a pretty significant 
basis…that has been unprecedented.”  
 
The difficulty in finding a provider, particularly a specialist, who accepts Medi-Cal, can lead to 
undue delays in receiving treatment. County hospitals have long wait times for appointments, 
and the uninsured have very limited options. Furthermore, the limited number of providers who 
accept Medi-Cal can also lead to disparities in quality of care. For example, multiple respondents 
pointed out that Medi-Cal recipients have less access to cutting-edge treatments being explored 
at institutions such as the UCLA Medical Center or City of Hope.  
 
This barrier is heightened for women on Medi-Cal, who may particularly have trouble finding 
oncologists that accept their plan, much less one that is located in a preferred, or conveniently 
located, facility. Providers further noted a challenge in identifying specialists for Medi-Cal 
patients, particularly plastic surgeons offering reconstructive surgery. One provider lamented the 
lack of choices for women in the program: 
 
“They don’t have necessarily the freedom of choice to go, even it’s difficult to get 
a second opinion with those insurances.  So I would say that’s probably one of the 
bigger barriers, at least in the state of California, is that for women under public 




Among key informants, it was not only simply lacking insurance or underinsurance that was 
perceived as a barrier, but also the challenges of enrollment and authorization among insured 
women- both publicly and privately insured.  
 
The insurance authorization process contributes to delays in care. A provider respondent said 
approvals for OncotypeDX, a genomic test that can help guide treatment decisions, can delay 
treatment up to a month and half. She noted that this is a new delay, as recently as 2014 the 
approvals were only taking two weeks. Barriers were less common with certain forms of 
treatment, namely surgery or chemotherapy. Consistent with our key informant interviews, a 
2013 study of breast cancer patients in California found that the prolonged insurance 
authorization process led to delays in performing diagnostic tests, thus delaying treatment 3 
months or more.39  
 
The delays due to authorization have even driven some women with private insurance to seek 
care from safety net providers. A patient navigator reported that some women had given up 
waiting for authorizations for procedures with their regular doctors and had turned to the 
community clinic for quicker access to biopsies, mammograms or surgeries. 
 
Providers were extremely familiar with issues in insurance approval processes, one specifically 
noting that the difference between the time from diagnosis to surgery can be 3-4 weeks for 
some, and nearly 2 months for others, particularly those on public programs. Another provider 
lamented about the bureaucracy of Medi-Cal plans: “when people are newly diagnosed with 
breast cancer, you know, ideally, they’re going to surgery within a two to four-week period and it 
can take me two to four weeks just to get their MRI approved. Never mind if they need more 
invasive testing like a PET-CT or an additional biopsy or whatever.” 
 
This barrier is seen when uninsured women start the screening process in a public program, such 
as Every Woman Counts (EWC). 
 
“Some women are already being referred, then they start seeing an oncologist 
before even getting BCCTP [Breast and Cervical Cancer Treatment Program] 
eligibility and then all of the sudden once they get eligibility they have to transfer 
care to somebody else so there might be a break in continuity of care. There also 
might be what I’m aware of one of the barriers is that usually it’s very difficult to 
find who will really take the case, and once they become managed care patients 
or Medi-Cal patients, they really don’t know where to go and who would be the 
right physician for them. Sometimes they don’t want to go to certain physicians 
so it’s a barrier when it comes to finding the right oncologist because, for 
example, you may be referred to an oncologist that your primary physician knows 
but once you receive Medi-Cal it’s not the oncologist that takes Medi-Cal and that 
might be the problem. I think that the continuity of care might be a huge issue, 
especially for our population (in EWC).” 
 
One provider noted: 
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“I definitely would combine my program (EWC) with BCCTP and make it more 
comprehensive in public health and I would say that the treatment program, the 800 
number, should be the number where the woman can get enrolled, at least presumptive 
eligibility. It will take a lot of different components to be established but I think that it 
would be great. Or at least that maybe EWC providers, Family PACT providers and BCCTP 
workers have equal access for patients’ enrollment.” 
 
Providers identified other barriers caused by insurance, including the lack of coverage under 
some plans for reconstructive surgery, genomic testing, support services, and second opinions. 
Two respondents specifically called out challenges of insurance coverage regarding inpatient vs. 
outpatient services. One provider noted he has had to admit patients in order to get a biopsy 
covered. He stated that from a system perspective, “that’s not the most cost-effective way of 
doing it.” 
 
Some of our key informant respondents worked with programs that helped uninsured and/or 
low-income patients sign up for insurance or public programs. This is perceived as helpful, but 
does not reach all populations.  
 
One key informant noted that undocumented women-- in particular cannot get biopsy services 
covered, and many are not having the procedure since they cannot afford to pay out of pocket. 
Some are not aware of assistance through public or charitable programs.  
 
Additionally, limitations and changes in access-enhancing programs interrupt continuity of care. 
For example, the length of public programs can become a barrier to completing treatment:  
 
“The (Breast and Cervical Cancer Treatment Program) BCCTP program is 18 
months. One woman did not know she could get reconstruction under the 
program in that time.”  
  
Providers can also suddenly opt out of programs: 
 
“Programs have limited shelf life…women go every two weeks or every so often 
to get (a specific) medicine. And then all of the sudden the doctor calls and says 
that medicine is not covered anymore and we’re not gonna see you.” 
 
Treatment delays may also be created by the eligibility process for insurance coverage:  
 
“I had one lady….one of the ladies that she cleaned the house for was going to 
help pay, you know, the $1000 consultation fee here out of pocket. But we 
couldn’t take her out of pocket, because of her Medi-Cal being in process. And so 
she kind of felt at a loss, because she wanted to get this started but the Medi-Cal 
was taking a long time to process her application.”   
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Recommendations to Address Insurance/Health Benefits Barriers 
 Review Medi-Cal provider rates and consider adjustments as necessary so they are more 
acceptable to providers. Women covered by Medi-Cal and the Breast and Cervical Cancer 
Treatment Program will face fewer delays in care if more providers can be incentivized to 
participate in the Medi-Cal program. 
 Streamline authorization processes and meet a set target for turnaround time. Women 
face delays in care due to prolonged insurance authorization, thus failing to receive 
timely treatment.   
 Evaluate health insurance plans for narrow provider networks specific to breast cancer 
diagnosis and treatment. Support investigation to quantify the extent to which narrow 
networks and the lack of providers accepting Medi-Cal lead to delays in care, and 
ultimately, adverse clinical outcomes. 
 Extend benefits for the Breast and Cervical Cancer Treatment Program beyond 18 
months. Due to delays in locating providers, authorization processes, and above all, the 
lengthy treatment course for some women (which can last 5 or more years), the BCCTP 
should be extended from 18 months to time deemed medically necessary to complete 
treatment.   
 Allow participation in Medi-Cal and Covered California regardless of immigration or 
documentation status.   
 Increase the patient’s awareness of a plan’s covered benefits for reconstructive surgery 
and second opinions. 
 Ensure continuity of care from screening, diagnosis to treatment for uninsured women 
screened by the Every Women Counts Program, and who transition to breast cancer 





A diagnosis of breast cancer is a catastrophic personal event that brings on stress and worry on 
how to pay for medical and non-medical bills associated with getting timely and appropriate 
care. 
 
Even for women covered under private insurance, access to and the high cost of copayment for 
oncology treatment and drugs is a commonly discussed issue in the literature and in key 
informant interviews. While the ACA requires states to establish marketplaces that allow the 
public to easily compare different healthcare plans, comparing costs and coverage of plans is not 
simple and consumers appear to have trouble deciding which plans to enroll in when choices are 
given.40  
 
Multiple reports have highlighted the cost of cancer drugs as a financial burden to patients 
receiving treatment. A study by the American Cancer Society Cancer Action Network (ACS CAN) 
revealed that cancer drugs are most often placed on the highest cost-sharing tier; in California, 
the coinsurance for the highest cost tier is 20%.41 ACS CAN authors also observed significant gaps 
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in the transparency of prescription drug coverage, and challenges to being able to compare and 
thus pick plans. In an analysis by Avalere Health looking at Covered California plans, they found 
plans tended to place all drugs used to treat complex diseases such as cancer on the highest 
formulary cost-sharing tier.42 Recent reports by California Health Care Foundation also suggest 
costs of drugs likely affects access to care.12,43  
 
Key informant interviews reinforced the studies that suggest low-income women who have 
insurance, but prohibitively high co-payments, face substantial barriers to care. One patient 
educator was succinct:  
 
“$100 is a lot of money if you have to go to the doctor three times a year.” 
 
In addition, cost of a second opinion is a major issue. There are some programs that offer free 
second opinions in an attempt to address these barriers, but as with other support services, they 
are not common, nor easy for patients to identify and locate.  
 
Both patient educators and providers voiced similar opinions as patient educators about co-pays, 
second opinions, and uncovered procedures: 
 
“It doesn’t matter what your income level is, when you have cancer, bills add up 
and priorities have to change.” 
and 
 
“There is so much hidden cost. I mean, just think about like well your copay is ten 
dollars, when you’re being worked up for breast cancer you’ve got ten visits in two 
weeks, that’s a hundred bucks that people don’t have. It doesn’t matter if you’re 
insured if you can’t afford to fill your car with gasoline.” 
 and 
“You know the bottom line is that a lot of these drugs cost a fortune of money, some of 
the newer medicines cost more.” 
 
Providers felt more could be done educating patients on how to manage costs. One provider 
stated: 
“I wish that would be mandatory [to talk to a financial counselor] because there are lots 
of financial people to talk to after you get bills, but there’s not a lot of people to talk to 
before you even get started.” 
 
Respondents also noted that low-income women are especially discouraged when, after 
receiving a free screening mammogram, discover that they face many expenses such as co-
payments and deductibles to obtain follow-up tests and treatments after a suspicious 
mammogram. Women may not be aware of programs such as Every Woman Counts that exists 
to help women with costs of treatment and follow-up, however individuals must meet financial 
requirements to qualify (income at or below 200% of federal poverty level and be uninsured or 
not able to afford payments if insured).   
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Providers were also aware that a fear of costs can cause some patients to delay or forego care, 
and this is a particular cause of frustration. “Particularly in the cancer world, I think the thing 
that’s hardest for those of us that work in cancer to see is people who are going to die of their 
disease when they could have been cured…” 
 
In addition to financial barriers related to paying for medical services, patients going through 
treatment may face additional cost barriers related to family care (if a patient needs household 
help during treatment), transportation to appointments, and/or childcare during treatment 
times. 
 
One respondent was very pointed about the perception that insurance equated to access: 
 
 “People who do not have a copayment seemed to have an easier time actually 
being able to go to their doctor’s appointment, if they have a sitter.” 
 
On transportation, one patient educator noted: 
 
“Okay, we can educate women all we want. We can give them the brochure with 
the number. We can call for them and we can make an appointment for them, 
but if they can’t physically get there because of transportation, we’ve failed them 
in that way.”    
 
A provider echoed this concern:  
 
“Sometimes (patients) don’t even have a bus fare, and I think that gets left out of 
some of the care models.” 
 
And all of this may be more complicated for patients for whom lost time at work means lost 
wages. Respondents noted the difficult choices faced by some patients on paying for expensive 
treatments and medications: 
 
 “She had to decide putting a roof over her and her children’s head and food on 
the table or pay for the Tamoxifen…and so, she wasn’t taking her Tamoxifen.”  
 
Several providers worked for organizations that provided support services for patients. Most of 
the services were funded by the organization, many through grants or private philanthropic 
efforts, or on-site partnerships with organizations such as the American Cancer Society (ACS). 
Services include navigation, social workers, psychosocial aid through support groups or peer-to-
peer connections, bodily care, and nutrition and exercise counselors. Some organizations were 
able to assist patients with transportation barriers through partnerships with local taxi 
companies or the ride-share company Uber. One medical director spoke of the importance of 
cooperation between providers and programs: 
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“That’s a whole other conversation, this artificial division between social services and 
healthcare. I believe that division is maintained because it’s easier for us to think about 
but there should be far more cooperation between healthcare and social services to 
make sure that there’s some kind of concerted effort around the whole person to 
maintain health and well-being.” 
 
Another commented:  
 
“People who are marginally housed, who are marginally employed who are trying 
to recover from surgery, keep their housing, you know, support their children, 
single mom’s trying to support small children recovering from surgery. I do see 
people who present with surgical complications that are essentially socially 
mediated; (they get) infections because they haven’t been taking their antibiotics, 
or they haven’t been taking care of their drains, or their wound is separating 
because they’ve been sic (hauling) their two-year-old around because there’s 
nobody to help take care of the baby. I see those things, not frequently but 
enough that I know it’s a problem. And those are very complex things. I mean I’m 
not sure that there are easy solutions to people’s complex and chaotic social 
environments, but it’s definitely something we see.” 
 
However, there is concern about the availability and sustainability of funds for support services, 
with one provider at a private practice complaining that these ancillary costs of battling a disease 
were not reimbursed, “Well the problem with support services is that the government does not 
compensate you for it. I mean that’s just the reality of it. You know it comes out of our hide.” 
 
One provider noted that there are also lasting impacts of breast cancer that require on-going 
support. While there are programs that may offer a mastectomy bra to patients during 
treatment, it will wear out and is expensive to replace. Insurance coverage for psychosocial 
support may also be limited, or nonexistent in some plans.  
 
Recommendations to Address Costs Barriers 
 Remove cancer drugs that are recommended by national clinical guidelines from the 
highest tiers. Drugs that are cited as standard of care, e.g. recommended by the National 
Comprehensive Cancer Network, should be removed from the highest tiers (and thus 
highest cost-sharing). 
 Provide financial assistance for co-payments and deductibles for breast cancer diagnosis 
and treatment services. Such assistance is particularly needed for women whose incomes 
are low enough to qualify for subsidies for Covered California premiums. 
 Provide financial assistance for non-medical costs, including transportation, childcare, 
and lost wages. 
 Provide tools, information and or financial counselors for consumers to make informed 
choices, including cost calculators, complete lists of all covered breast cancer drugs, up-
to-date formularies which includes information on tiers and restrictions on drug access, 
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and up-to-date and complete provider directories and information on in and out of 
network use of providers and costs. 
 Consider health system reform cost containment strategies that increase affordability of 
breast cancer care.  
 
Individual and Cultural Characteristics 
 
Sociodemographic factors also lend themselves to barriers experienced by breast cancer 
patients. These include personal traits such as employment/economic situation, personal 
support system and educational attainment, as well as lifestyle choices. Individuals are also 
impacted by their racial/ethnic identity and affiliation with cultural communities.  
 
In the peer-reviewed literature on barriers to breast cancer care, a number of descriptive studies 
on the disparities in breast cancer incidence, mortality and quality of care by race/ethnicity and 
socioeconomic status. 3,34,35,54-58 While racial/ethnic differences in breast cancer mortality may 
very well be related to tumor characteristics, aggressiveness of the cancer, and biologic response 
to treatment, disparities may also be attributed to differences in stage at diagnosis and the 
quality of breast cancer care received. Results of studies conducted among women from four 
racial/ethnic groups (African American, Asian American, Latina, and non-Latina White) in the 
California Breast Cancer Survivorship Consortium suggest that even after adjusting for age, 
tumor characteristics, and lifestyle, compared with non-Latina Whites, the breast cancer-specific 
mortality is higher for African Americans, lower for Latinas, and lowest for Asian Americans.59,60 
Compared to other racial/ethnic groups, African American women in California are the most 
likely to present at late stage of diagnosis. Nonetheless, African American women have the 
highest breast cancer screening rates (African American 67%, Hispanic 56%, non-Hispanic white 
63%, Asian/PI 55%),61 which suggests that screening is not driving stage of diagnosis. It is 
possible that other barriers, such as those stemming from insurance status, may impede African 
American women from receiving a timely diagnosis and timely access to treatment.  
 
Although some barriers to receiving breast cancer care such as lack of appropriate health 
insurance are universal, other barriers may be specific to a particular cultural group. The 
literature retrieval covering the period 2013-2015 generated a few papers on the impact of 
culture on the breast cancer experience among Asian Americans,2,62 Hmong immigrants,63,64 
Latinas,65,66 Jordanian- and Palestinian American women,67 however these papers were largely 
concerned with perceptions regarding screening and survivorship. There were, however, key 
informant interview responses that point to cultural barriers to breast cancer treatment. For 
example, several respondents noted that there is a lack of awareness, as well as myths and 
misconceptions, about breast cancer and treatment in many ethnic minority communities. One 
community educator heard women from a particular culture say that they believed 
mammograms caused breast cancer. A few providers serve in communities with enclaves of the 
population who prefer non-traditional, alternative medicine. Adhering to those preferences may 
cause patients to delay or completely forego modern medical solutions.  
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Across several cultures, perspectives on cancer is linked to fatalistic beliefs.68 Women from these 
cultures may perceive cancer as a death sentence, and they simply accept it or may not even 
want to know when it is present. They hear stories from other women who have had 
chemotherapy about all of the negative aspects to the process.  
 
Our respondents also noted that in some cultures, health is just not discussed. Consequently, 
women may be unaware that they are at increased risk for breast cancer due to family history.   
 
This can be particularly evident to primary care physicians who first detect a health problem and 
refer patients to others for further care. Primary care providers reported having some patients 
return without having seen other providers (specialists), saying they had no one who could take 
time from work to give them a ride, or no one to take over home care duties during treatment. 
Similarly, respondents are aware that many patients experience guilt in taking time away from 
their own responsibilities, and may delay treatment seeking due to fear of being a burden on 
their family. One provider shared: 
 
“Some take care of family members and they are caregivers and so there’s an 
inherent guilt, not sure who else is going to help them take care of their family 
member who has a stroke.” 
 
Some respondents noted specifically that there seemed to be a lack of familiarity and 
understanding of the Family Medical Leave Act (FMLA). Several providers hear patient concerns 
about taking the time from work themselves to undergo treatment, much less having an eligible 
family member miss days at work. One social worker respondent shared her efforts to educate 
patients:  
 
“I spend a lot of time talking to families about FMLA, about the medical leave 
that’s available to them, you know, for the 12 weeks of guarantee because lots of 
times you know they’re not aware that they can take time off to take a loved one 
to an appointment or that that is covered and that they have that as part of their 
protection and I think once I start explaining that on a regular basis to some of my 
patients’ families then it was like, oh, we could do this.” 
 
Our findings are consistent with substantial prior research, conducted in California and 
throughout the country that has found racial/ethnic differences in attitudes towards breast 
cancer and perceived barriers to accessing breast cancer services.69-75 
 
In our literature retrieval, we found that in a study of Latinas with abnormal mammograms, 
ethnic differences in communication needs and experiences with health-care providers 
appeared to contribute to delays in obtaining care.76 While Latinas and Non-Latina White women 
differed in how they rated their comprehension of abnormal results and follow-up care, both 
groups felt empathic communication was important. Patient-provider 
interaction/communication was found to be an important predictor of well-being and quality of 
life in large longitudinal study of women enrolled in the California Breast and Cervical Cancer 
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Treatment Program examined 921 low-income women with breast cancer. Better patient 
perceptions of patient-physician interactions were found to be associated with better mental 
well-being and quality of life. Patients reporting having received more information from 
providers, reported better mental well-being and quality of life; patients reporting having 
received more emotional support from their doctors reported better well-being; and, patients 
reporting having received more social support reported having better quality of life.   
 
Our key informants shared examples of how cultural differences impact provider interactions 
with patients, above and beyond linguistic differences. One respondent representing an 
organization that focuses on Black women noted she often heard that her clients do not have 
providers that talk to them in a language (culturally) that they can understand. She reported this 
was also an issue for Asian American and Pacific Islander women. Beyond language barriers, 
many women who are ethnic minorities would see a provider from their same racial/ethnic 
group, which they feel can improve communication and satisfaction with care.   
 
Both key informants and the reviewed literature identified extensive barriers experienced by 
women with limited English proficiency. These findings were considered so substantive as to 
merit a separate discussion, presented below (see Language).   
 
Respondents described the anxiety that goes beyond the fears associated with diagnosis, 
treatment, and affordability. Fear and stigma in certain cultures cause women to keep diagnosis 
to themselves, adding to their personal burden. Women who are caregivers and feel a cultural 
obligation to take care of others also fear of what happens to their families. Many face questions 
of disclosure Keeping a breast cancer diagnosis private can be very important in some 
communities, and women with this perception may be willing to take long bus rides to see a 
provider that is from outside of their cultural and geographical community. Respondents 
reported that women from some cultures feel there is a shame in being a burden and try to 
avoid burdening others with their breast cancer diagnosis. These fears can lead to delays in 
seeking care and locating a provider for breast cancer treatment. 
 
Breast cancer patients have care needs that are outside their course of treatment. While some 
services such as support groups are not covered by insurance, others services might be. One 
provider specifically noted that she has specific language needed to get wigs covered by Medi-
Cal. But some experience cultural barriers to seeking and utilizing support services. Just as 
patients may prefer providers that they can relate to culturally, patients feel more comfortable 
identifying with a navigator of the same culture.  
 
“People may be more inclined to follow through…if they would have someone 
who is from their own community who speaks (culturally) like them.”  
 
Similarly, women are most comfortable joining a support group with women who look like they 
do, and speak the same language (see Language). Several respondents noted the need for more 
culturally appropriate services.  
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“Some people tell me that the support groups didn’t look like them, so they kind 
of felt like they didn’t belong, and they didn’t go back.” 
 
While barriers to support services were not often associated with insurance status, providers 
discussed the barriers that were particular to socially-disadvantaged women: 
 
“Educated and empowered women will often access those services whether the 
cancer program offers them, and if it doesn’t then they’ll go find them someplace 
else, right? So, some of my patients are seeing the naturopaths, and 
chiropractors, and getting lymphatic cranial sacral massages every day, and they 
have all that tuned up. A lot of my low income and non-English speaking patients, 
we have trouble even getting them in to see the nutritionist, and maybe they 
don’t understand why it’s important or they don’t have time or they’re working or 
they don’t have a ride or, you know, I think it can be hard to, it can be hard to 
compensate for the fact that people who have tremendous social stress don’t 
have a lot of extra bandwidth for those services, even when they’re available.” 
 
Geography does not eliminate barriers to care, it may just change the type of barriers most 
prevalent. It is well established that rural cancer patients across the U.S. face challenges in 
receiving oncology care, stemming largely from the limited availability of cancer treatments and 
cancer support providers, transportation and financial limitations, and poor access to clinical 
trials.77 Rural women have also been shown to be less likely to receive radiation therapy for 
breast cancer compared to their urban counterparts.78,79  
 
While our key informant interviews commented that rural areas often have a small number of 
providers and fewer transportation options for access both care and support services, 
respondents from urban areas - where there are a higher number of providers - reported similar 
barriers. Large urban areas have more options (like specialists can accommodate multiple 
languages) and better public transportation systems, but can be more difficult to navigate than 
less densely populated communities. One respondent noted that if a patient “doesn’t have 
transportation and the doctor’s office is on the other side of town, even though they live in LA, 
it’s still an hour or two hours away.”  
 
Providers also noted challenges that distance created for some of their patients. Often, larger 
hospitals and those connected to academic centers are sought for second opinions. A provider in 
Santa Monica noted she has people from Bakersfield, more than 100 miles away, seeking second 
opinions. Providers also note that at times the referral system in an insurance plan with narrow 
networks sends patient’s great distances:   
 
“…we do care for people that come from as far away as 150 miles away, even 
when they’re geographically closer to a Stanford or UCLA, the referral pattern is 
this way just because culture or farming communities and we take care of that.” 
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Still, inequities in cancer treatment may in part be due to where patients go to get care.  
Geographic variation in breast cancer surgery rates has been examined by the California Health 
Care Foundation (CHCF).80 CHCF found breast cancer patients in several California communities 
undergo mastectomy, lumpectomy, radiation, and other treatments for breast cancer at rates 
notably higher or lower than other communities and the California rate. 
 
Recommendations to Address Individual and Cultural Barriers 
 State programs such as the Office of Health Equity should provide resources and 
programs to encourage cultural competency training for health providers on breast 
cancer care. 
 Design and implement payment models that reward providers and larger health delivery 
systems that provide culturally appropriate services to patients who need them. 
 Provide additional funds to breast cancer screening programs, such as Every Woman 
Counts, to conduct community education and outreach to address fears and stigma 
regarding breast cancer diagnosis and treatment. 
 Increase awareness of Family Medical Leave Act (FMLA) that may provide time off for 
employees to obtain treatment or to recover from treatment. 
 Support telehealth services to improve a patient’s geographic access to providers and 




The literature suggests patients may experience challenges understanding the communication 
they receive from their health care provider, made worse when English is not their first 
language.76,82-93 Even patients who are proficient in English (or the language of their health care 
provider) may not understand complicated, technical medical terms and may have low health 
literacy. Health literacy, as defined by the US Department of Health and Human Services,  is “ the 
degree to which individuals have the capacity to obtain, process, and understand basic health 
information and services needed to make appropriate health decisions.”81 These patients may 
have difficulty understanding instructions from the doctor, and medication instructions from the 
pharmacist. Even some patients who can verbally understand instructions may have difficulty 
reading written instructions from a health care provider or follow-up appointment notifications 
sent through the mail. In addition, printed educational materials are often not available for all of 
the diverse immigrant communities of California. This is a challenge given interpretation is only 
available at the doctor’s office and cannot help patients overcome barriers to understanding 
written materials once at home.  
 
Even within the doctor’s office, interpreter service has its challenges. Starting in 2009, 
California’s Health Care Language Assistance Act went into full effect, requiring health insurers 
(except self-insured health plans) to cover translation services, at least by telephone, while 
visiting their doctor, pharmacist, ophthalmologist, and dentist. Medi-Cal, Medicare and most 
health plans are subject to that law, thus key informants did not call out any differential barriers 
by insurance status.  However, an analysis of the California Health Interview 2015 points to 
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differential language service need by insurance status:  among women age 30 and older, over 
half of the uninsured and about 40% of women covered by Medi-Cal are limited English 
proficient (LEP), compared to under 10% of the commercially insured who are LEP 
(askchis.ucla.edu).  Although these estimates are not limited to women who have been 
diagnosed by breast cancer, these population estimates suggest that language assistance 
services are most needed for women who are uninsured or covered by Medi-Cal.  
 
Moreover, despite California’s language assistance mandate, many study respondents felt there 
was a lack of interpreters overall, and indicated that interpreters were often not available for the 
full interaction between a patient and a provider’s office. For example, although an interpreter 
can be called in for the brief period when the patient actually sees the physician, interpretation 
is often not available for interactions with the front office staff when in the waiting room, or for 
making clinic appointments, or completion of insurance paperwork. Clinic staff often do not have 
the language skills to fill in when interpreters are not available and in-person interpretation is 
not available in all languages (for example, Hmong). One respondent had heard a patient was 
told by a doctor to change providers in order to access an interpreter.  
 
For LEP patients who are likely to be uninsured or on Medicaid, community health centers 
(CHCs) may provide the culturally and linguistically competent services that they need.  Yet, CHCs 
function in a primary care setting and breast cancer treatment is delivered in hospital and 
specialty settings.  Thus, CHCs may at times take on more of the uncompensated language 
bridging role for their LEP patients across the continuum of cancer care.   One primary care 
provider serving predominantly a low-income Asian population noted that while her clinic had 
staff speaking multiple languages, they had only one local oncology option for referring patients 
whose primary language was Mandarin. Some respondents who worked in practices that had 
extensive in-office language services (one provider noted 12 at her organization), expressed 
concerns about referring their patients needing language services to facilities that were not co-
located, since then they would lose control over the ability to make sure patients received 
services. 
 
LEP patients may also not be aware of their right to an interpreter and thus rely on family 
members to bridge the communication with their doctors. In some cases, key informants noted 
that cultural and language issues can clash. Providers shared that children in Hmong and Middle-
Eastern households may be resistant to sharing a negative diagnosis with their parents, causing 
doctors to feel caught between their obligation to the patient and the sensitive nature of the 
family interactions. Cultural/family dynamics issues aside, because of quality and safety risks, the 
ACA (section 1557) includes a final rule that requires plans offer qualified interpreters to their 
patients, and bans minor children and family members to serve as interpreters except in 
emergency situations.  Knowledge and compliance of this final rule could reduce language 
barriers to cancer care. 
 
Many resources available through public programs, support groups, and online are limited to 
English, and perhaps Spanish. This presents a barrier to even searching for support services or 
resources on eligibility for public insurance or public programs such as the BCCTP.  One provider 
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also noted that support groups are not available for less common languages, and suggested 
making smaller peer-to-peer connections would be extremely valuable. “They’re not going to 
come to an English-speaking support group, we do some peer-to-peer matching so that people 
who are non-English speaking…we try to match them with a linguistic speaker, somebody in their 
language group who’s had a similar experience and try to facilitate them at least having a peer 
support person in addition to the support staff.” 
 
Recommendations to Address Language Barriers 
 Require coverage or reimbursement for interpretation and translation services that 
extend beyond the visit, to include the entire span of the care experience such as making 
appointments, patient education, and support services. 
 Support the integration of language services with patient navigation services through the 
promotion of programs that provide language training to navigators and enhance the 
availability of translation services to navigators. 
 Expand the number of providers who are bilingual. 
 Enforce compliance of the law of the Health Care Language Assistance Act and the ACA 
section 1552 across all health plans especially Medi-Cal plans that serve a 
disproportionate number of LEP patients. 
 Encourage health plans to convey the right to an interpreter and to facilitate in-language 
peer-support programs for LEP patients. 
 Support the primary care safety net’s efforts in language bridging services across the 
breast cancer care continuum in specialty and hospital care. 
 Establish programs for limited-English proficient women to increase their awareness of 










Concerns about a Repeal of the Affordable Care Act (ACA, Obamacare) 
 
In 2017, under the new presidential administration, federal legislation regarding changes to the 
ACA, and state policy actions in response, may disrupt coverage for many Californians. Changes 
in the healthcare landscape may further increase barriers and challenges to accessing timely and 
appropriate breast cancer care. Due to the timing of the second round of interviews, health care 
providers were asked specifically for their perceptions regarding anticipated impacts of the 
federal proposals. We note that some interviews occurred prior to the House bill vote and all of 
the interviews occurred prior the CBO scoring of the House bill.  
 
Under the ACA breast cancer care was impacted in several ways. The bill mandated that 
insurance plans cover preventive screenings with no cost-sharing, removed lifetime coverage 
limits, and forbid plans to refuse coverage or impose increased costs for pre-existing conditions, 
crucial for any woman who experiences recurrences in breast cancer. Most respondents felt the 
removal of provisions for the individual mandate and rules requiring plans to cover pre-existing 
conditions would be damaging to the whole health care system. 
 
“The whole purpose of the mandate as I understand it is to make sure the system 
is paid for. If young people, you know, specifically young people, people who feel 
invincible, don’t pay into the system, then the system would collapse because the 
system would have to be held up by people who are sick…. (and) a system that 
allowed insurers to reject and at best charge extra to people with preexisting 
conditions which prevented them from moving around and finding the best 
health care was ridiculous…..So these changes, you know, they’re going to send 
us back to the dark ages of healthcare” 
 
Two of the 11 providers did expect little to no impact on care and access for breast cancer care, 
feeling California’s generous public programs provide adequate, even generous, care. One 
provider shared this assessment: “I don’t think much will happen, honestly. I don’t. They got 
access to care beforehand and they’ll get access to care afterwards. I mean that’s just a reality. 
They show up to the emergency room, they get treated and they get referred. I mean before the 
ACA I took care of a lot of people pro bono, you know, and drug companies provided medicines.  
Sometimes it was even more timely.” 
 
The remaining provider participants voiced concerns about the levels of uninsured increasing, as 
well as the number of patients seeking care in emergency rooms (ER) and safety net facilities.  
 
“I trained at L.A. County and at L.A. County, you know, people would walk in, this 
was before Obamacare, I was down there in 2008, 9, and 10, you know, people 
would walk in off the streets with these fumigating tumors, you know, infected 
and bleeding, well I knew there was something wrong but I didn’t have insurance. 
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And I don’t know how many times I’ve heard that refrain in my career, it’s just 
sickening.” 
And 
“A few years ago when there were more uninsured patients, like before the 
Affordable Care Act, I think one big barrier was access at that time, like wait times 
to see specialists were higher because we had to send more patients to Highland 
and there were fewer specialists accepting – there were fewer patients with 
Medi-Cal so there were fewer specialists you could send them to.” 
And 
“I think 90 percent of our patients who are insured, publicly-insured, would go 
back to an uninsured status which means that they would end up getting the 
county insurance again which, you know, if you’re siphoning everyone towards 
the county there, you’re going to get increase in your ER admissions, right, ER 
visits. You’re going to have decreased, just access to primary care, decreased 
access to specialists that they would potentially need to see. I mean there’s 
medications that they can’t even continue taking (if they become uninsured 
again.”   
 
Most providers agreed that reverting to a system similar to that before the ACA would 
significantly increase the number of uninsured patients, which would cascade into other barriers 
increasing as well as public programs, and the providers that serve them, absorb more patients.  
 
Summary and Conclusion 
 
While medical technology and clinical treatment of breast cancer has improved significantly over 
the years, barriers to cancer care still vex the healthcare system and contribute to delays 
between each step along the breast cancer care continuum and may even block a person from 
receiving a specific service/treatment, or a prematurely end access to a service/treatment. This 
report examined barriers and challenges to accessing breast cancer care in California by 
insurance status using a multi-method approach, including a synthesis of the peer reviewed 
literature, news media, reports and policy briefs, social media, a legislative scan, and a series of 
key informant/stakeholder interviews. This assessment synthesized the findings from these 
differing yet interlinked sources of information, producing the themes as well as specific barriers 
identified as the most significant for women with breast cancer in California.  
 
After collecting data on the key barriers to breast cancer treatment faced by women in 
California, the barriers were organized into common themes or categories.  Five themes were 
identified:  (1) Health System Fragmentation, (2) Insurance/Health Benefits, (3) Cost, (4) 
Individual and Cultural Characteristics, (5) Language/Health Literacy. Using this organization 
structure, the key informant interviews – leaders in patient education, support, and navigation 
and oncology providers– offered a wealth of insight regarding recommendations for 
improvement. We provide specific policy recommendations for each of these themes above that 
can be used to guide efforts of policy-makers to improve timely access to breast cancer care 
among all women in California. We provide below in Table 2 policy insights that hone in on the 
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issues of key concern identified in this report for the five identified themes by insurance type. 
We hope that potential solutions can be found in policy remedies that address these key issues 
and affect global changes at the health care system level and assistance for nonclinical support 
services for breast cancer patients. 
 
Table 2. Policy Insights by Theme and Insurance Type 
Themes Uninsured & 
underinsured 





State policy that 
bolsters the 
preservation of 
coverage for the 
uninsured given 









under the ACA & 
policy focus on 
specifically 
improving the 
quality of care 
provided to Medi-
Cal enrollees to 
address disparities 
that currently exist  
 
State policy targeted 
to the ensuring 
subsidy support for 
Covered California 
and ensure low 
income population 
has access to 
navigation and 




these services, and 
promotion of 
system integration 
State policy to mandate navigation services, reimbursement for these services, and 
consideration of payment models that encourage care coordination  
Insurance/Health 
Benefits 
Policy mandates to 
extend program 
















Policies that limit 
narrow provider 
networks, with focus 
on improving 




of a plan’s covered 
benefits for 
reconstructive 
surgery and second 
opinions. 
 
Policies that streamline authorization processes and meet a set target for 
turnaround time. Women face delays in care due to prolonged insurance 
authorization, thus failing to receive timely treatment  
 
Cost State policy that 
bolsters the 
preservation of 
coverage for the 
uninsured given 
the uncertainty of 
the ACA; 
 







childcare, and lost 
wages 
State policy targeted 
to the ensuring 
subsidy support for 
Covered California; 
 
Policies that restrict 
placement of 
essential oncology 
drugs on the highest 
cost tier and other 
Policies to reduce 
the burden of costs 
to enrollees from 
treatment and 







Themes Uninsured & 
underinsured 









policies that address 
high costs of 
oncology drugs 
tools to consumers 
regarding costs of 
care, for example 
cost calculators, lists 
of all covered breast 
cancer drugs, up-to-
date formularies & 
information on tiers 
and restrictions on 
drug access, 
provider directories 
and information on 
in and out of 
network use of 
providers and costs 
 Consider health system reform cost containment strategies that increase affordability 
of breast cancer care.  
 








women to ensure 
timely treatment 
Establish funding 









services to improve a 
patient’s geographic 




provider’s ability to 




models that reward 





to patients who 
need them 
 
State programs such as the Office of Health Equity should provide resources and 
programs to encourage cultural competency training for health providers on 






proficient women  
to increase their 
awareness of 




(BCCTP)  for breast 
cancer care  
Incentivize 
providers more to 
provide language 





with payment for 
in-language 
navigation services 




that extend beyond 
the visit, to include 
the entire span of the 




and support services 
Support programs 
that expand the 
number of 
providers who are 
bilingual, and 
incentivize the use 
of language services 
Enforce compliance of the law of the Health Care Language Assistance Act and the 
ACA section 1552 across all health plans especially Medi-Cal plans that serve a 















A conceptual framework was developed to illustrate and organize the different types of barriers 
that might limit access to breast cancer diagnostic and treatment services. Figure 1 illustrates 
this conceptual framework, juxtaposing the breast cancer care continuum from 
prevention/screening to treatment initiation and post-treatment care with the barriers and 
delays that might limit access to breast cancer diagnostic and treatment services at the 
individual, provider, and system levels. While barriers may occur anywhere along this continuum 
of breast cancer care that spans from prevention to rehabilitation, our review focuses on the 
care that occurs from diagnosis of the cancer to treatment. We thus exclude preventive services, 
early-detection/screening and post-treatment and rehabilitation in this report.  
 
 
Figure 1.  Conceptual Framework of Breast Cancer Barriers for Diagnosis and Treatment  
 
 
Patient level characteristics, such as race/ethnicity, age, and comorbidities influence not only 
what we call patient-level barriers, such as language, financial status, access to transportation, 
family support, but likely also impact the provider/practice and health system barriers. For 
example, patient’s ethnicity is associated with provider communication style2 and an individual’s 
residential neighborhood is associated with quality of care.3 Barriers may contribute to delays 
between each step along the breast cancer care continuum, complete lack of access to a service, 
or a premature end to treatment. While some patient level characteristics are unchangeable 
(e.g., demographics), policies and programs can be used to overcome many barriers. Thus, our 
discussions below focus less on research documenting disparities, and more on research and 
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observations identifying modifiable barriers that can be used to inform the development of 
policies and programs to improve access to breast cancer care in California.  
 
MeSH and Keywords Search 
As part of our review, we included both the peer-reviewed literature as well as non-peer 
reviewed sources. Utilizing the methodology used to generate reviews of medical effectiveness 
by the California Health Benefits Review Program (http://chbrp.ucop.edu), a literature search 
was performed to retrieve publications that described any aspect of barriers to breast cancer 
care. The conceptual framework (Figure 1) helped identify search terms (see list of terms).  The 
literature search was limited to articles published in English from 2013-2015. The following 
databases that index peer-reviewed journals were searched: PubMed (MEDLINE), the Cochrane 
Library, and Web of Science. The list below includes all search terms used for the review – we 
used search strategies that included MeSH terms, which generate specific and very targeted 
responses, along with keyword searches that cast a wider net and can capture the most recent 
papers which MeSH searches may miss. All results were filtered to include only papers in English 
with human subjects. Because there were only a handful of California-based studies, U.S. based 
studies were also included in the literature pull.  We also reviewed the non-peer reviewed 
material for our specified time frame retrieved from LexisNexis Academic database, Google 
News Archives, and Google (reports and news sources).   
 
MeSH terms used to search PubMed Keywords 
Breast Neoplasms (all searches included this 
MeSH term) 
Used one by one with AND “breast neoplasms”) 
Costs and Cost Analysis 
Patient Protection and Affordable Care Act 
Health Expenditures 
Drug Costs 


















Used one by one with AND “breast cancer” AND 
“access to care”) 
Barriers to care 
Access to care 
Delay in care 




Costs of care 
Prescription drug costs 
Cost sharing 
Out of pocket costs 
Patient costs 











Appendix A.1 Citation List of Literature (2013-2015) Identified for Abstraction  
Author Title Journal Year Level Geography 
Adepoju L, Wanjiku S, Brown M, et al.  
 
Effect of insurance payer status on the 
surgical treatment of early stage breast 







American Cancer Society Cancer Facts & Figures 2016. ACS 2015 Patient-level USA 
American Cancer Society Cancer Action Network ACS CAN Examination of Cancer Drug 
Coverage and Transparency in the 
Health Insurance Marketplaces 
ACS CAN 2015 System-level USA 
Ashing-Giwa, K.; Rosales, M.; Lai, L.; Weitzel, J. Depressive symptomatology among 
Latina breast cancer survivors 
Psychooncology 2013 Patient-level California 
Avalere Health Exchange Benefit Designs Increasingly 
Place All Medications for Some 
Conditions on Specialty Drug Tier 
Avalere Report 2015 System-level USA; California 
Bestvina, C. M.; Zullig, L. L.; Yousuf Zafar, S. The implications of out-of-pocket cost 
of cancer treatment in the USA: a 
critical appraisal of the literature 
Future Oncol 2014 Patient-level, 
System-level 
USA 
Bickell, N. A.; Paskett, E. D. Reducing inequalities in cancer 
outcomes: what works? 







Bourdeanu L, Luu T, Baker N, Swain-Cabriales S, 
Chung CT, Mortimer J, Hurria A, Helton S, Smith D, 
Ferrell B, Juarez G, Somlo G. 
Barriers to treatment in patients with 
locally advanced breast cancer. 







Bradley, C. J.; Wilk, A. Racial differences in quality of life and 
employment outcomes in insured 
women with breast cancer 
J Cancer Surviv 2014 Patient-level; 
System-level 
Virginia 
Bradley, C.J. Economic recovery: A measure of the 
quality of cancer treatment and 
survivorship? 
J Cancer Surviv 2014 Patient-level USA 
    
Brot-Goldberg Z, Chandra A, Handel B, Kolstad J.   What Does a Deductible Do? The Impact of 
Cost-Sharing on Health Care Prices, 
Quantities, and Spending Dynamics.
  
NBER Working Paper 




California Cancer Registry California: Cancer Facts and Figures 
2014 
CCRC 2015 Patient-level California 
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California Healthcare Foundation.  Medi-Cal Versus Employer-Based 
Coverage: Comparing Access to Care 
CHCF 2015 System-level California 
California Healthcare Foundation.  Early-Stage Breast Cancer Treatment in 
California: A Close-Up of Geographic 
Variation 
CHCF 2013 System-level California 
California Healthcare Foundation.   California Employer Health Benefits: 
Rising Costs, Shrinking Coverage: 
CHCF 2015 System-level California 
Dominick, S. A.; Natarajan, L.; Pierce, J. P.; Madanat, 
H.; Madlensky, L. 
Patient compliance with a health care 
provider referral for an occupational 
therapy lymphedema consult 
Support Care Cancer 2014 Patient-level California; San Diego 
Dowling, E. C.; Chawla, N.; Forsythe, L. P.; de Moor, 
J.; McNeel, T.; Rozjabek, H. M.; Ekwueme, D. U.; 
Yabroff, K. R. 
Lost productivity and burden of illness 
in cancer survivors with and without 
other chronic conditions 
Cancer 2013 Patient-level, 
System-level 
USA 
Dusetzina, S. B.; Muluneh, B.; Khan, T.; Richards, K. 
L.; Keating, N. L. 
Obstacles to affordable cancer 
treatments 
N C Med J 2014 System-level USA 
Flores, Y. N.; Davidson, P. L.; Nakazono, T. T.; 
Carreon, D. C.; Mojica, C. M.; Bastani, R. 
Neighborhood socio-economic 
disadvantage and race/ethnicity as 
predictors of breast cancer stage at 
diagnosis 





Gabitova, G.; Burke, N. J. Improving healthcare empowerment 
through breast cancer patient 
navigation: a mixed methods 
evaluation in a safety-net setting 





    
Gomez SL, Shariff-Marco S, DeRouen M, et al. The impact of neighborhood social and 
built environment factors across the 
cancer continuum: Current research, 
methodological considerations, and 
future directions. 





Gorey, K. M.; Luginaah, I. N.; Holowaty, E. J.; Zou, G.; 
Hamm, C.; Balagurusamy, M. K. 
Mediation of the effects of living in 
extremely poor neighborhoods by 
health insurance: breast cancer care 
and survival in California, 1996 to 2011 
Int J Equity Health 2013 System-level California 
Grant SR, Walker GV, Koshy M, et al.   Impact of Insurance Status on 
Radiation Treatment Modality 
Selection Among Potential Candidates 
for Prostate, Breast, or Gynecologic 
Brachytherapy. 
International journal 





Gunn, C. M.; Clark, J. A.; Battaglia, T. A.; Freund, K. 
M.; Parker, V. A. 
An assessment of patient navigator 
activities in breast cancer patient 




Author Title Journal Year Level Geography 
navigation programs using a nine-
principle framework 
Navigation) 
Haeder SF, Weimer DL, Mukamel DB. California hospital networks are 
narrower in Marketplace than in 
commercial plans, but access and 
quality are similar. 
Health Affairs 2015 System-level California 
Hahn, E. E.; Ganz, P. A.; Melisko, M. E.; Pierce, J. P.; 
von Friederichs-Fitzwater, M.; Lane, K. T.; Hiatt, R. A. 
Provider perceptions and expectations 
of breast cancer posttreatment care: a 
University of California Athena Breast 
Health Network project 





Haji-Jama S, Gorey KM, Luginaah IN, Balagurusamy 
MK, Hamm C. 
Health insurance mediation of the 
Mexican American non-Hispanic white 
disparity on early breast cancer 
diagnosis 





Hershman, D. L.; Tsui, J.; Meyer, J.; Glied, S.; Hillyer, 
G. C.; Wright, J. D.; Neugut, A. I. 
The change from brand-name to 
generic aromatase inhibitors and 
hormone therapy adherence for early-
stage breast cancer 
J Natl Cancer Inst 2014 Patient-level USA 
Hershman, D. L.; Tsui, J.; Wright, J. D.; Coromilas, E. 
J.; Tsai, W. Y.; Neugut, A. I. 
Household net worth, racial disparities, 
and hormonal therapy adherence 
among women with early-stage breast 
cancer 
J Clin Oncol 2015 Patient-level USA; black/white 
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Hutchins, V. A.; Samuels, M. B.; Lively, A. M. Analyzing the affordable care act: 
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Kapoor, A.; Battaglia, T. A.; Isabelle, A. P.; Hanchate, 
A. D.; Kalish, R. L.; Bak, S.; Mishuris, R. G.; Shroff, S. 
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The impact of insurance coverage 
during insurance reform on diagnostic 
resolution of cancer screening 
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J Health Care Poor 
Underserved 
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Barriers reported among patients with 
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patient navigation research program: 
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Keegan, T. H.; Kurian, A. W.; Gali, K.; Tao, L.; 
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Appendix B.  Frequency of Coded Response 
 Overall, there were 24 codes organized into five main categories.  
Category Code Phase 1 Phase 2 












System Barriers      
   Insurance (Approvals) 3 6 6 10 
 Continuity of Care 2 4 2 4 
 Access/Narrow Network 
(including Timely Access) 
7 11 7 9 
Navigation        
 Navigation/Provide a Path 
(Need for and Benefits of) 
7 23 1 1 
 Availability of Information 8 10 3 3 
 Provider Knowledge 2 4 2 2 
 Decision Making 5 5 0 0 
 Patient Follow-Through 1 1 0 0 
 Support/Stability 7 9 1 1 
 Fear/Anxiety (about 
treatment, support) 
6 6 1 1 
Cost        
  Cost of Care 10 10 6 7 
 Transportation 4 5 6 6 
 Homelessness 1 1 1 1 
 Financial Assistance (Need for) 3 3 0 0 
 Work Constraints 3 3 5 6 
 Insurance (Status) 10 20 3 4 
Culture/Individual 
Characteristics 
       
  Stigma 2 4 2 2 
 Culturally Appropriate 
Services and Treatments 
2 2 3 3 
 Myths and Misconceptions 3 3 2 2 
 Rural/Urban 3 3 2 2 
Language – impact        
 Provider Communications 
(Understanding the doctor, 
staff, materials) 
5 10 1 1 
 Language barrier to 
information/support services 
4 6 9 10 
 Health Literacy 
(understanding condition, 
treatment options) 
4 4 7 7 
 Interpreter Availability 4 4 0 0 
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Appendix C. Social Media Search  
Methods 
We examined Twitter and Facebook for discussions pertaining to breast cancer and barriers to 
cancer care (see below for hashtags). Other web platforms were also examined to pull any 
discussions regarding breast cancer barriers to care; these include, Tumblr, Wordpress, Blogger, 
reddit, and message boards and patient forums and blogs, patient stories on breast cancer 
websites (Susan G. Komen, American Cancer Society, Pink Ribbon and Breast Cancer Action) for 
discussion and stories related to breast cancer barriers and for shared perspectives on the 
patient experience.  
 
Our examination of social media was challenged to find high-volume discussions on breast 
cancer barriers on Twitter and Facebook (publicly available posts). This is not to say that 
discussions are not occurring, as it is possible that these conversations are occurring privately in 
Facebook groups or other non-publicly accessible platforms and chat sites. While searching via 
the hashtags #breastcancer and #barriers via Twitter, a public platform, generated very few 
relevant results, we identified a number of Twitter chats hosted by an organization called Living 
Beyond Breast Cancer (LBBC; Twitter @LivingBeyondBC), which Approachs to connect people 
with breast cancer information and community support. Throughout 2014 and 2015, 
@LivingBeyondBC has hosted a number of chats for patients that deal with issues related to 
breast cancer treatment decision making, coping with high costs, financial impacts of breast 
cancer, and follow-up care.  In general, there is an incredibly large volume of Tweets (namely 
tweeting and re-tweeting posts related to news articles in major sources, such as the New York 
Times) on larger health system and health trend topics – not specifically related to breast cancer, 
rather to health care in general - such as those related to the high cost of drugs, high co-pays, 






o Search for “breast cancer”  
o https://medium.com/search?q=breast%20cancer 





 Google search: “breast cancer” “California” “treatment” “blog” (1M results) 
 
Breast Cancer Support Sites – Webpage and Facebook, Twitter Sites 
 Susan G. Komen 
o Stories of inspiration http://ww5.komen.org/StoriesofInspiration.html 
o Message Boards: Forum [Treatment] [Dealing with Insurance, Employment and Disability] 
https://apps.komen.org/Forums/tt.aspx?forumid=68 American Cancer Society 
 Pink Ribbon? 
 What Next (recommended by KP as online resource: https://www.whatnext.com/) 
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o Questions: Search term: insurance 




 Breast Cancer Action (SF based advocacy org with social justice mission, advocates basically against money 
going to Pink Ribbon) 
o Blog: http://www.bcaction.org/blog/ 
o Twitter: @BCAction 
 Cancercare 
o Stories of Help and Hope 
 http://www.cancercare.org/stories (Not sure if stories are good,  not specific to California 
and usually more positive?) 
 American Cancer Society 
o Cancer Survivors Network http://csn.cancer.org/?_ga=1.257476808.25899981.1456465484 
 Discussion Boards: Search “insurance”, Limit to 2014-2015 
 http://csn.cancer.org/forum/127/search?page=32&body=insurance&title= 
o MyLifeLine.org- cancer social networking 






o “breast cancer” “California” – limited to posts in the past year 
 
 Breastcancer.org  
o Discussion Boards:  
 Tests, Treatments and Side Effects: Help Me Get Through Treatment 
 Search “California,” limit to past 2 years 
 Day-to-Day Matters: Employment, Insurance, and Other Financial Issues 
https://community.breastcancer.org/forum/113 
 Search “California”, limit to past 2 years 
 AskMetaFilter 
 Yahoo! Answers 
 
Twitter chats 
  (@LivingBeyondBC) 
o 10/22/15 #JACR Tweet Chat about imaging during breast cancer diagnosis, treatment and follow-
up 
o 12/2/15 #LBBCchat Now What? Making Treatment Decisions After Diagnosis 
o 10/15/15 #LBBCchat Breast Reconstruction 
o 6/25/14 #LBBCchat Coping with the Financial Impact of Breast Cancer 
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Appendix D. Legislative Scan Approach 
 
Methods 
Using http://leginfo.legislature.ca.gov, bills were first examined by searching “breast cancer” and then scanned for themes related to 
addressing barriers to care.  In a second stage, we then searched for bills that addressed barriers to care that were not specific to 
breast cancer: care integration, patient navigation, health plan network adequacy, Medi-Cal reimbursement and access, cost-sharing, 
costs of drugs, costs of non-medical care, and language and linguistic access. We screened bill titles and text to select legislation that 
was specific to health care systems, delivery and coverage. 
California Legislation Related to Breast Cancer, 2013-2016 
Bill 
Number 
Year  Title Content Status (as of 
5/11/2016) 
AB-1795 2016 Health care programs: cancer Extends the time limit for the Breast and Cervical Cancer Treatment Program from a set number months (18 




ACR-68 2015 Breast Cancer Awareness and Prevention 
Month. 
Designate October as Breast Cancer Awareness Month Passed 
AB-1396 2015 Public health finance Transfer funds from California Tobacco Tax Act of 2015 Fund to other funds that currently receive revenue 
from tobacco taxes, including the Breast Cancer Fund, that are expected to decline under the additional new 
taxes imposed by the California Tobacco Tax Act of 2015, due to decreases in tobacco consumption 
Not passed 
SBX2-14 2015 Tobacco: electronic cigarettes: taxes: 
managed care organization provider tax: 
in-home supportive services 
Include e-cigarettes in tobacco taxes, continue to allocate revenues to same funds including Breast Cancer 
Funds 
Not passed 
SB-69 2015 Budget Act of 2015 Allocating funds for Breast Cancer Control Account Not passed 
AB-103 2015 Budget Act of 2015 Allocating funds for Breast Cancer Fund, Breast Cancer Control, and Breast Cancer Research Not passed 
AB-93 2015 Budget Act of 2015 Allocating funds for Breast Cancer Fund Passed 
AB-1598 2016 Budget Act of 2016 Allocating funds for Breast Cancer Fund In review: Assembly 
Budget  
SB-825 2016 Budget Act of 2016 Allocating funds for Breast Cancer Fund In review: Sen 
Budget and Fiscal 
Review 
AB-94 2015 Health Continuation of breast and cervical cancer early detection program Passed 
SB-75 2015 Amendments to Professional code Continuation of breast and cervical cancer early detection program Passed 
AB-731 2015 Maintenance of the codes Payment parity of breast and cervical cancer early detection program with Medi-Cal, breast cancer license 
plates 
Passed 






Year  Title Content Status (as of 
5/11/2016) 
AB-657 2013 Women's health  Revises guidance to DPH on literature it produces on breast cancer Not passed 
AB-1286 2013 Personal income tax: voluntary 
contributions: California Breast Cancer 
Research Fund 
Allows taxpayers to designate contribution to Breast Cancer Research Fund Passed 
AB-219 2013 Health care coverage: cancer treatment Limits co-pays and co-insurance to $200 per prescription for oral anticancer medications Passed 
SB-768 2013 Cigarette and tobacco products taxes: 
California Tobacco Tax Act of 2014 
Transfer funds from California Tobacco Tax Act of 2014 Fund to other funds that currently receive revenue 
from tobacco taxes, including the Breast Cancer Fund, that are expected to decline under the additional new 
taxes imposed by the California Tobacco Tax Act of 2014, due to decreases in tobacco consumption 
Not passed 
AB-1278 2013 Integrative cancer treatment Sets requirements for providers offering "integrative" cancer treatment, i.e. alternative or complementary 
treatment, of cancers; repeals one code on unprofessional conduct regarding breast cancer informed 
consent? 
Not passed 
AB-110 2013 Budget Act of 2013 Allocating funds for Breast Cancer Fund, Breast Cancer Control, and Breast Cancer Research Passed 
AB-73 2013 2013-14 Budget Allocating funds for Breast Cancer Fund, Breast Cancer Control, and Breast Cancer Research Not passed 
SB-65 2013 2013-14 Budget Allocating funds for Breast Cancer Fund, Breast Cancer Control, and Breast Cancer Research Not passed 
AB-1457 2014 Budget Act of 2014 Allocating funds for Breast Cancer Fund, Breast Cancer Control, and Breast Cancer Research Not passed 
SB-851 2014 Budget Act of 2014 Allocating funds for Breast Cancer Fund, Breast Cancer Control, and Breast Cancer Research Not passed 
SB-852 2014 Budget Act of 2014 Allocating funds for Breast Cancer Fund, Breast Cancer Control, and Breast Cancer Research Passed 
SB-1304 2014 Maintenance of the codes Regulations on independent review for worker's compensation (cancer is mentioned in the case of consulting 
with NCI); sets minimum contribution levels for Breast Cancer Research Fund; regulations from Health and 
Safety code around exposures to chemicals known to cause cancer 
Passed 
AB-1219 2015 California Cancer Task Force Requires a joint task force to coordinate DHCS Breast and Cervical Cancer Treatment Program with DPH 
screening activities 
Not passed 
SJR-19 2015 Women's reproductive health Statement of support for Planned Parenthood Passed 
SB-804 2015 Public health Requires DHCS to report to legislature quarterly on caseload, expenditures, program monitoring data for the 
Every Woman Counts Program (breast and cervical cancer early detection and screening) 
Passed 
SB-1426 2014 Breast and Cervical Cancer Treatment 
Program 
Revises Health and Safety Code to read that provider eligibility determined by CMS (rather than HCFA) Not passed 
ABX-1-1 2013 Medi-Cal: eligibility Exempts women in Breast and Cervical Cancer Treatment Program from semiannual reporting requirements 
for eligibility determination: Changing Medi-Cal determinations from semiannually to annually but requiring 
semiannual reports 
Passed 
SB-77 2013 Health Requires DHCS to report on Every Woman Counts; requires cosmetics manufacturers to report chemical risks 
of cancer 
Not passed 
AB-82 2013 Health Requires DHCS to report on Every Woman Counts; requires cosmetics manufacturers to report chemical risks 
of cancer 
Passed 




We found few examples of legislation that specifically addressed barriers in diagnosis and 
treatment of breast cancer from 2013 to April 2016.   
 
 We identified provisions within bills that exempted breast cancer treatment from 
proposed cuts in Medi-Cal reimbursement.   
 Another bill contained a provision requiring breast and cervical cancer screening 
programs, i.e. Every Woman Counts, to provide information on insurance coverage for 
women who receive services through their program.  
 A bill that limited the cost-sharing for oral anticancer medications was passed in 2013. 
 More often, we found legislation that continued funding for breast cancer screening and 
outreach, breast cancer research, and the Breast and Cervical Cancer Treatment Program 
(but no changes to the program).    
 We found one bill (AB 1795, 2016, under review by Committee on Appropriations) that 
directly addresses coverage for breast cancer treatment. This bill proposes to extend the 
time limit for the Breast and Cervical Cancer Treatment Program from a set number of 
months (18 for breast cancer) to the time needed to complete treatment. Given the 
delays in locating providers, as well as treatment regimens such as hormonal therapies 
that continue for multiple years, this type of policy addresses a barrier for particularly 
vulnerable women would not otherwise have coverage for care.  
 
We found bills that addressed costs and access to healthcare, and breast cancer patients could 
potentially benefit.   
 
 Legislators proposed multiple bills Approached at network adequacy within health plans 
and limits on cost-sharing in general as well as specifically for prescription drugs.   
 Legislation to provide reimbursement for interpreter services has been passed and 
vetoed twice.   
 We also identified bills specific to other health conditions that could serve as examples 
for policy on breast cancer, such as subsidies for copayments and deductibles, network 
adequacy of specialists, and bundled Medi-Cal payments for integrated health, 
behavioral and social services.  
Notably, 
 
 We found no legislation that addressed patient navigation services for cancer care.   
 We found no legislation that mandated insurance coverage for patient navigation 
services for clinical or supportive care. 
 We found no legislation that addressed network adequacy specific to breast cancer care, 
or cancer care in general. 
 We found no legislation that addressed the numerous costs that patients experience 
outside of direct medical care for breast cancer.  
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 We found no legislation that addressed Provider-Patient Interactions, Cultural Barriers, or 
Fear and Stigma, specific to breast cancer or applicable to breast cancer patients. 
 We found vetoed legislation that addressed language barriers: AB-1263 (2013) and AB-
2325 (2014), which would have required the Department of Health Care Services to 
establish CommuniCal, a program to provide and reimburse for medical interpreter 
services. 
 
Health System  
The Fragmented Health System    We found no legislation specifically addressing the challenges 
of receiving breast cancer care across a fragmented set of providers and services.   
 
AB-1568 (2016) and SB-815 (2016) propose to establish the PRIME (Public Hospital Redesign and 
Incentives in Medi-Cal) program, which would offer payment incentives to safety net hospitals to 
redesign systems to better integrate and coordinate services.  Both bills are currently under 
review by the Committee on Appropriations.  If passed, the PRIME program could serve as a 
vehicle for a health system to develop a coordinated path of breast cancer treatment for low-
income women. 
 
Other    To address the lack of access to clinical trials among minority and other underserved 
populations, AB-1060 (2015, vetoed) and AB-1823 (2016) have proposed the creation of a 
Cancer Clinical Trials Program that would be administered by the University of California.  The 
program would offer grants to providers, community-based organizations, or other services such 
as patient navigator programs, to increase patient access to clinical trials. AB-1823 is currently 
under review by the Committee on Appropriations.  
Navigation 
We found no legislation that addressed patient navigation services for cancer care.   
 
AB-94 and SB-75 (2015, passed) were both omnibus health bills that, among other measures, 
proposed the State Department of Public Health create the Pre-Exposure Prophylaxis (PreP) 
Navigator Services Program for communities and populations at high risk for HIV infection.  The 
program would award grants to community-based organizations or local health departments. 
We also found one example of legislation that Approachs to provide information to assist 
enrollees in navigating health care.  SB-571 (2015, not passed) proposed to create CalCareNet, 
website to assist with navigation of long-term care services. 
 
These bills offer examples of how the state could support patient navigator services for breast 
cancer care.  We found no legislation that mandated insurance coverage for patient navigation 
services for clinical or supportive care. 
Insurance 
Narrow Provider Networks    We found no legislation that addressed network adequacy specific 
to breast cancer care, or cancer care in general. 
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We found multiple examples of legislation addressing network adequacy.  SB-964 (2014, passed) 
required the Department of Managed Health Care to establish health plan standards for 
timeliness of care and network adequacy, and required plans to submit reports annually on 
network adequacy.  SB-137 (2015, passed) requires health plans to publish updated provider 
directories, both print and online, with provider location and acceptance of new patients, and 
languages spoken by provider and staff. 
 
We found one example in which legislation addressed network adequacy for a single type of 
care/treatment.  Both AB-796 and SB-1034 (2016) required health plan network adequacy for 
autism service providers. Both bills are in review (Committees on Health and Appropriations). 
 
Public Programs    We found two types of legislation that addressed Medi-Cal provider 
reimbursement.  First, SB-243 (2015, not passed) proposed an increase of Medi-Cal hospital 
rates to 16% and physician rates to parity with Medicare reimbursement.  Second, omnibus 
health bills (AB-94, SB-75) contained provisions to exempt breast and cervical cancer treatment 
from cuts in Medi-Cal provider reimbursement.  Thus, Medi-Cal reimbursement rates while 
inadequate, have neither been increased nor decreased for breast cancer care. 
 
We identified one bill, AB-209 (2013, not passed), that would have required the Department of 
Health Care Services to develop and implement a plan to monitor quality, access and utilization 
in Medi-Cal managed care plans.  This is the only example we could identify of legislation that 
addressed barriers around lack of providers who accept Medi-Cal and the quality of care 
provided. 
 
In regards to eligibility and authorization for Medi-Cal, SB-1005 (2015, not passed) proposed that 
all individuals who would otherwise qualify for full-scope Medi-Cal benefits, were it not for their 
immigration status, to be eligible for Medi-Cal.  SB-1005 also proposed that all eligible individuals 
may participate in Covered California as well.   
 
AB-94 and SB-75 also contained provisions to require that state breast and cervical cancer 
screening programs, i.e. Every Woman Counts, provide enrollees with information on applying 
for insurance coverage. 
Cost 
Out of Pocket Costs-- Cost-Sharing and High Deductible Health Plans   We found one example of 
legislation that was specific to out-of-pocket cancer costs, AB-219.  This bill proposed that co-
payments and co-insurance be capped at $200 per 30-day prescription for oral anti-cancer 
medications, with increases tied to the Consumer Price Index. AB-219 was passed and signed 
into law in 2013.    
 
We found multiple examples of legislation that addressed general out-of-pocket costs for 
enrollees. SB-639 (2013, passed) set limits for deductibles and out-of-pocket maximums for small 
group health plans.  Small group bronze plans were exempted from these limits if they would 
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render the plans unable to meet actuarial requirements.  The deductibles under this legislation 
($2000 per individual or $4000 for family) are considerably lower than the Covered California 
plans examined in this report, although the out-of-pocket maximum costs are similar ($6350 for 
individual/$12,700 family). AB-1305 (2015, passed) set limits on out-of-pocket maximums for 
individuals within families.  SB-1176 (2014, not passed) would have required to health plans to 
monitor out-of-pocket spending for enrollees and reimburse payments over the out-of-pocket 
maximum within five days.  
 
AB-533 (2015, not passed), would have prohibited an out-of-network provider from charging an 
enrollee for cost-sharing in excess of in-network cost-sharing.  In the case of breast cancer care, 
this is salient for women with Covered California plans in rural areas who have difficulty finding 
local in-network specialists such as surgeons, oncologists and radiation oncologists.  Enrollees 
are required to pay any excess amounts charged by out-of-network providers, and this costs are 
not subject to the out-of-pocket maximum. 
 
We found multiple examples of legislation that addressed the cost of prescription drugs.  AB-
2436 (2016, passed) requires health plans to provide information on enrollees’ share of cost for 
prescription drugs.  AB 2144 (2016, in committee) SB-715 (2015, not passed) would have 
authorized (not required) health plans to provide coverage for investigational drugs.  AB-1917 
(2014, not passed) would have limited cost-sharing a single prescription drugs to 1/12 the annual 
out-of-pocket limit. 
 
We found one example of legislation that addressed out-of-pocket costs specific to a health 
condition.  AB-1462 (2014, not passed) included a provision that authorized the State 
Department of Public Health to subsidize costs to health plans, including copayments, 
deductibles and premiums, for HIV treatment if such a program would lower overall costs to the 
state.  A similar case could be made for breast cancer, if cost-sharing burdens lead to delayed or 
missed care.  
 
Costs Beyond Care   We found no legislation that addressed the numerous costs that patients 
experience outside of direct medical care for breast cancer.  
 
AB-1568 (2016) and SB-815 (2016) proposed the Whole Patient pilot as part of a larger Medi-Cal 
demonstration project bill. The pilot would allow providers to receive capitated payment for a 
range of health, behavioral and social services; for breast cancer patients, such a program could 
provide coverage for needs such as transportation, meals, childcare and financial assistance.  
Both bills are under review by the Committee on Appropriations. 
 
Individual and Cultural Characteristics 
We found no legislation that addressed Provider-Patient Interactions, Cultural Barriers, or Fear 




AB-1263 (2013, vetoed) and AB-2325 (2014, vetoed) would have required the Department of 




Appendix F. Summary Tables and Figures 
 
Heat map table of barrier types addressed in the key informant interviews, peer-reviewed, non 
peer reviewed literature, and social media 
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